SCPH

scPharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website cpharmaceuticals.com
Employees(FY) 96
ISIN US8106481059

Performance

+2.42%

-3.69%

-35.55%

-15.04%

-45.93%

YTD

-43.59%

Profile

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Advanced Technical Analysis

Technical Analysis of SCPH 2024-12-20

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 30 indicating a bearish outlook, while the Oscillators Score of 53 suggests a neutral stance, and the overall Technical Score of 41 reinforces a bearish sentiment. This combination implies caution, as the prevailing indicators do not signal strong bullish momentum.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of SCPH

Stock Rank

Recent News & Updates

2024-11-13 13:15
scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...(Yahoo Finance)
2024-11-13 04:20
ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates(Yahoo Finance)
2024-11-13 03:01
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-11-06 03:01
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024(Globenewswire)
2024-10-14 20:30
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024(Globenewswire)
2024-09-04 04:05
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference(Globenewswire)
2024-08-15 21:55
Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect?(Yahoo Finance)
2024-08-14 23:57
Q2 2024 scPharmaceuticals Inc Earnings Call(Yahoo Finance)
2024-08-14 05:20
ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-08-14 04:01
scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-08-11 21:48
scPharmaceuticals Announces Pricing of $50.0 Million Public Offering(Globenewswire)
2024-08-11 18:05
scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors(Globenewswire)
2024-08-11 18:04
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure(Globenewswire)
2024-08-11 18:02
scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector(Globenewswire)
2024-08-11 18:00
scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants(Globenewswire)
2024-08-08 04:05
scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024(Yahoo Finance)
2024-07-24 20:00
scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease(Globenewswire)
2024-07-14 23:57
7 Short-Squeeze Stocks That Could Beat Down the Bears(Investorplace)
2024-06-05 00:55
These 2 Strong Buy Penny Stocks Are Poised for a Massive Rally, Say Analysts(Yahoo Finance)
2024-05-29 04:01
scPharmaceuticals to Present at the Jefferies Global Healthcare Conference(Globenewswire)
2024-05-14 23:44
Q1 2024 scPharmaceuticals Inc Earnings Call(Yahoo Finance)
2024-05-14 20:18
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript(Insidermonkey)
2024-05-14 15:09
scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...(Yahoo Finance)
2024-05-14 08:56
SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024(Investorplace)
2024-05-14 05:20
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates(Zacks)
2024-05-14 04:01
scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-05-13 04:05
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference(Globenewswire)
2024-05-07 04:05
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024(Globenewswire)
2024-04-23 20:00
scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection(Globenewswire)
2024-03-16 03:57
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript(Insidermonkey)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.